Unresectable Malignant Solid Neoplasm Suspended Phase 1 Trials for Olaparib (DB09074)

IndicationStatusPhase
DBCOND0110416 (Unresectable Malignant Solid Neoplasm)Suspended1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04585958
Testing the Combination of DS-8201a and Olaparib in HER2-Expressing Cancers With Expansion in Patients With Endometrial CancerTreatment